Author

M. D. Powell

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Immunology· 2 Microbiology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cell type annotation· 2 Approach:experimental assay· 2 Research Focus:host-pathogen & immune response· 2 Organism:mouse· 2 Research Focus:cell signaling & trafficking· 1 Research Focus:development & morphogenesis· 1 Organism:human· 1 Assay:proteomics· 1

Frequent Co-Authors

D. M. Jones· 2 shared J. A. Tuazon· 2 shared K. A. Read· 2 shared K. J. Oestreich· 2 shared R. T. Warren· 2 shared A. D. Raymond· 1 shared A. G. Freud· 1 shared A. Saadey· 1 shared

Activity by Year

2019-2022 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 33 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersImmunology

D. M. Jones

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

Eos promotes TH2 differentiation by propagating the IL-2/STAT5 signaling pathway.

J. A. Tuazon, K. A. Read, B. K. Sreekumar, M. J. Yaeger, S. Varikuti, D. M. Jones, R. T. Warren, M. D. Powell, M. N. Rasheed, E. G. Duncan, L. M. Childs, K. M. Gowdy, K. J. Oestreich

This study identifies Eos as a positive regulator of TH2 cell differentiation by enhancing IL-2/STAT5 signaling in CD4+ T cells.

bioRxiv · Nov 2, 2022 · PreprintImmunology

Aiolos modulates the TFH and CD4-CTL differentiation programs via reciprocal regulation of the Zfp831/TCF-1/Bcl-6 axis and CD25

K. A. Read, D. M. Jones, S. Pokhrel, E. D. S. Hales, A. Varkey, J. A. Tuazon, C. D. Eisele, O. Abdouni, A. Saadey, R. T. Warren, M. D. Powell, J. M. Boss, E. A. Hemann, J. S. Yount, H. E. Ghoneim, , K. J. Oestreich

This study identifies Aiolos as a regulator of TFH and CD4-CTL differentiation, showing it modulates the Zfp831/TCF-1/Bcl-6 axis and suppresses the cytotoxic gene program.

bioRxiv · May 18, 2022 · PreprintImmunology

Plasma-derived HIV Nef+ exosomes persist in ACTG384 study participants despite successful virological suppression.

A. D. Raymond, M. J. Lang, J. Chu, T. Campbell-Sims, M. B. Khan, V. C. Bond, R. B. Pollard, D. M. Asmuth, M. D. Powell

The paper measures Nef+ exosomes in HIV+ patients on ART and finds they persist despite viral suppression and correlate with CD4 recovery patterns.

bioRxiv · Jul 20, 2019 · PreprintMicrobiology